Compare Dishman Pharma with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs FDC LTD. - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA FDC LTD. DISHMAN PHARMA/
FDC LTD.
 
P/E (TTM) x 25.1 20.6 122.1% View Chart
P/BV x 3.3 3.1 108.0% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   FDC LTD.
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
FDC LTD.
Mar-18
DISHMAN PHARMA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs374319 117.4%   
Low Rs129164 78.6%   
Sales per share (Unadj.) Rs197.861.6 320.9%  
Earnings per share (Unadj.) Rs21.29.9 213.1%  
Cash flow per share (Unadj.) Rs34.712.0 290.2%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs179.973.2 245.9%  
Shares outstanding (eoy) m80.69174.40 46.3%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.33.9 32.5%   
Avg P/E ratio x11.924.3 48.9%  
P/CF ratio (eoy) x7.220.2 35.9%  
Price / Book Value ratio x1.43.3 42.4%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,30642,118 48.2%   
No. of employees `0000.85.5 15.0%   
Total wages/salary Rs m5,3552,167 247.1%   
Avg. sales/employee Rs Th19,252.71,943.7 990.5%   
Avg. wages/employee Rs Th6,459.5391.7 1,648.9%   
Avg. net profit/employee Rs Th2,064.1313.7 658.0%   
INCOME DATA
Net Sales Rs m15,96110,751 148.5%  
Other income Rs m265510 52.1%   
Total revenues Rs m16,22611,260 144.1%   
Gross profit Rs m4,1032,267 181.0%  
Depreciation Rs m1,091351 310.4%   
Interest Rs m94414 6,745.7%   
Profit before tax Rs m2,3342,411 96.8%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624671 92.9%   
Profit after tax Rs m1,7111,735 98.6%  
Gross profit margin %25.721.1 121.9%  
Effective tax rate %26.727.8 96.0%   
Net profit margin %10.716.1 66.4%  
BALANCE SHEET DATA
Current assets Rs m11,0187,213 152.8%   
Current liabilities Rs m9,5172,104 452.4%   
Net working cap to sales %9.447.5 19.8%  
Current ratio x1.23.4 33.8%  
Inventory Days Days11054 202.8%  
Debtors Days Days3528 125.7%  
Net fixed assets Rs m16,3046,865 237.5%   
Share capital Rs m161175 92.1%   
"Free" reserves Rs m12,90712,586 102.5%   
Net worth Rs m14,51612,761 113.7%   
Long term debt Rs m4,1896 69,823.3%   
Total assets Rs m29,80515,041 198.2%  
Interest coverage x3.5173.2 2.0%   
Debt to equity ratio x0.30 61,384.2%  
Sales to assets ratio x0.50.7 74.9%   
Return on assets %8.911.6 76.6%  
Return on equity %11.813.6 86.7%  
Return on capital %17.519.0 92.5%  
Exports to sales %24.812.3 200.8%   
Imports to sales %3.70-   
Exports (fob) Rs m3,9561,327 298.2%   
Imports (cif) Rs m596NA-   
Fx inflow Rs m4,9521,889 262.1%   
Fx outflow Rs m6970-   
Net fx Rs m4,2551,889 225.3%   
CASH FLOW
From Operations Rs m2,7861,498 186.0%  
From Investments Rs m-1,529201 -760.3%  
From Financial Activity Rs m-941-1,694 55.5%  
Net Cashflow Rs m31610 3,071.8%  

Share Holding

Indian Promoters % 61.4 68.9 89.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.7 78.7%  
FIIs % 12.7 7.5 169.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.1 19.0 116.3%  
Shareholders   46,261 23,730 194.9%  
Pledged promoter(s) holding % 35.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  SHASUN PHARMA  

Compare DISHMAN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 271 Points Higher; Capital Goods and Realty Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours today and ended higher. Benchmark indices regained momentum amid huge buying seen in capital goods and realty stocks.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 8-QTR ANALYSIS

COMPARE DISHMAN PHARMA WITH

MARKET STATS